ZCCHC8 and neoplasm: Fusion ZCCHC8--RSRC2, previously detected in several tumor studies (Yoshihara et al. 2015; Hu et al. 2018; Dehghannasiri et al. 2019; Jang et al. 2020; Haas et al. 2023), was identified as highly prevalent and broadly expressed across cell types in HGSOC Patient-3 tumor and matched normal samples, identified in 46% and 36% of sequenced cells, respectively.